Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Lixisenatide

Summary

Risk. The use of amino acids, proteins, and peptides is not considered to pose any environmental impact. Even though biomolecules, such as vaccines and hormones, are exempted they should still be regarded as biologically active.

 

This summary information comes from Fass.

Detailed information

Fass environmental information

Fass environmental information for Lyxumia (lixisenatide) (downloaded 2019-04-26).

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00) vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment.

Even though biomolecules, such as vaccines and hormones, are exempted they should still be regarded as biologically active.

References

  1. Fass för vårdpersonal.
  2. European Medicines Agency, EMA: Committee for Medicinal Products for Human Use (CHMP). Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006.

Author: Health and Medical Care Administration, Region Stockholm